Old Web
English
Sign In
Acemap
>
authorDetail
>
Dewal Jani
Dewal Jani
Novavax
Virology
Immunology
Antibody
Adjuvant
Immunogenicity
3
Papers
210
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age
2017
Vaccine
Allison August
Gregory M. Glenn
Eloi Kpamegan
Somia P. Hickman
Dewal Jani
Hanxin Lu
D. Nigel Thomas
Judy Wen
Pedro A. Piedra
Louis F. Fries
Show All
Source
Cite
Save
Citations (61)
A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age
2016
The Journal of Infectious Diseases
Gregory M. Glenn
Louis F. Fries
D. Nigel Thomas
Gale Smith
Eloi Kpamegan
Hanxin Lu
David Flyer
Dewal Jani
Somia P. Hickman
Pedro A. Piedra
Show All
Source
Cite
Save
Citations (109)
ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans.
2015
Vaccine
Ka Yan Chung
Elizabeth M. Coyle
Dewal Jani
Lisa R. King
Rukmini Bhardwaj
Louis Fries
Gale Smith
Gregory M. Glenn
Hana Golding
Surender Khurana
Show All
Source
Cite
Save
Citations (40)
1